Real-World Data on Apatinib Efficacy - Results of a Retrospective Study in Metastatic Breast Cancer Patients Pretreated With Multiline Treatment

Real-World Data on Apatinib Efficacy - Results of a Retrospective Study in Metastatic Breast Cancer Patients Pretreated With Multiline Treatment

ObjectivesThe NCCN guidelines recommend that the addition of bevacizumab should be considered in metastatic breast cancers in some circumstances, but there are no recommendations for the similar antiangiogenic drug apatinib. The aim of this study was to evaluate the safety and efficacy of apatinib i...

Full description

Bibliographic Details
Main Authors: Zhaoyun Liu, Jing Shan, Qian Yu, Xinzhao Wang, Xiang Song, Fukai Wang, Chao Li, Zhiyong Yu, Jinming Yu
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Oncology
Subjects:
breast cancer
apatinib
metastatic
efficacy
safety
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.643654/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.643654/full

Similar Items